Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Zhejiang Huahai
Pharma
Merck, Sinopharm agree on deal for China rights to Lagevrio
Merck has granted Sinopharm exclusive import and distribution rights to its COVID-19 oral antiviral Lagevrio in China.
Kevin Dunleavy
Sep 28, 2022 11:36am
Takeda, Eisai, US-China audit deal—Fierce Pharma Asia
Aug 26, 2022 10:10am
Pfizer tabs controversial Chinese firm Huahai to make Paxlovid
Aug 23, 2022 3:36pm
Biocon-Viatris, AstraZeneca, Huhai and more—Fierce Pharma Asia
Nov 19, 2021 8:20am
Valsartan recall protagonist comes off FDA warning letter
Nov 15, 2021 10:35am
Sanofi, AZ, Lilly and more win in China's expanded purchase bid
Sep 25, 2019 11:02am
